Repligen Corporation
RGENMedical Instruments & Supplies
$176.94−6.20%As of Oct 30vs prior close
- Market cap
- $11.2B
- P/E (TTM)
- –
- P/E (FY1)
- 85.4×
- From 52W high
- −9.06%
- EPS (LTM)
- -$0.20
- Revenue (LTM)
- $805.6M
- Net margin
- -1.47%
- Dividend yield
- 0.00%
Nomior Score
50
Crowded AscentTop 50% of the scored universe
Growth58
Quality47
Value30
Momentum70
Resilience49
Growth
+24.26%revenue a year over 9 fiscal years
FY16 $104.5MLTM $805.6M
Connections
Revenue to profitQ3 FY26
The operating loss was 14% of revenue, wider by 23 pts on a year.
Who owns it
2funds, 3 tracked portfolios